Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.67
+0.42005.79%
Post-market: 7.670.00000.00%17:56 EDT
Volume:138.11K
Turnover:1.11M
Market Cap:44.94M
PE:-0.67
High:8.65
Open:8.00
Low:7.43
Close:7.25
Loading ...
Dec 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 04, 2021

Major Issues Report

8-K - Current report
Sep 29, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]